08.00-09.30   HALL 2


Late Breaking Clinical Trials 2


Chairs: Peter J. Blankestijn, Utrecht, The Netherlands
            Vladimir Tesar, Prague, Czech Republic

Impact of parathyroidectomy and cinacalcet use on survival in chronic hemodialysis patients: the COSMOS study

Jorge B. Cannata-Andía, Oviedo, Spain

Investigation of serious adverse events in bardoxolone methyl patients in BEACON

Colin Meyer, Irving, USA

High serum calcification propensity is associated with mortality and graft failure in renal transplant recipients

Charlotte Keyzer, Groningen, The Netherlands

A double-blind placebo controlled randomized trial of ferric citrate coordination complex for the treatment of iron-deficiency anemia and reduction of serum phosphate in patients with non-dialysis dependent chronic kidney disease

Geoffrey Block, Denver, USA

Diagnosis and prediction of progression of chronic kidney disease by assessment of urinary peptides

Harald Mischak, Hannover, Germany


back to the timetable